Richard Jefferson believes that biotechnology can be used to benefit the poor and disenfranchised, but only if the R&D process is democratized so that everyone has access to critical scientific tools and technologies.
Richard Jefferson is the founder and CEO of Cambia, a Brisbane, Australiabased nonprofit that is trying to transform the way that we create new crops, drugs, and other biologically based products. Today, the biotechnology revolution is dominated by large multinational corporations, such as Monsanto, that use patents, access to capital, and other means to control critical technologies. As a result, the products that are developed are largely ones that maximize profits, not solve pressing...
Want more? Sorry, the full text of this article is only available to subscribers. Subscribe now.
Already a subscriber? Please log in by entering your email address and password into the red login box at the top-right corner of this page.
Need to register for your premium online access, which is included with your paid subscription? Register here.